Scoped data-science projects
For foundations and non-profits. Epidemiology, cohort analyses, evidence synthesis, registry design, and decision-grade reports — sized to the question, not to a retainer.
Mechanistic evidence services
We package biomedical research expertise into focused, scoped engagements for foundations, non-profits, biotechs, and rare-disease funds. Led by an epidemiologist and data scientist — from variant reports and cohort analyses to grant writing, RFP review, and scientific strategy advisory. Each engagement also calibrates the Artana Evidence platform.
Grant writing and review
NIH, NSF, foundation, and venture-philanthropy proposals. Drafting, scientific framing, and independent peer review against the funder’s rubric.
RFP review
Structured technical and scientific review of submitted proposals for foundation and non-profit funding rounds. Alignment scoring against funding-call criteria, conflict-of-interest handling, and reviewer notes ready for the committee.
Scientific strategy advisory
Translational roadmaps, biobank design, basket-trial rationale, and mechanism-grouped portfolio framing for foundations and early-stage biotechs. The shape of the program before the spend.
Mechanistic variant reports
Patient foundations and academic labs. Variant-level mechanism, structural context, and cross-species evidence assembled into a decision-ready report.
Cohort analysis + basket-trial rationale
Biotech and pharma R&D. Mechanism-defined patient cohorts across diseases, with the supporting evidence FDA basket-trial submissions require.
Mechanistic diligence
Rare disease funds. Independent assessment of the mechanistic basis behind a target, asset, or company. Pre-investment or pre-partnership.
Each engagement generates evidence that trains the platform. That’s the compounding asset that distinguishes us from a consulting firm.
Background reading
Want to understand what we build before scoping an engagement?